Cowen and Company’s OSR Health OSRH Stock Holding History

Cowen and Company’s Portfolio OSRH Stock Details OSRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-185,761	Closed	-$2.02M	–	425
2024 Q3	$2.02M	Sell	185,761 -7,615	-4%	-$82.4K	0.07%	117
2024 Q2	$2.08M	Sell	193,376 -176,476	-48%	-$1.89M	0.06%	117
2024 Q1	$3.94M	Buy	369,852 +354,102	+2,248%	+$3.76M	0.15%	71
2023 Q4	$165K	Buy	+15,750	New	+$165K	0.01%	221
2023 Q2	–	Sell	-63,300	Closed	-$639K	–	633
2023 Q1	$639K	Buy	+63,300	New	+$639K	0.08%	105

Other funds holding OSRH

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cowen and Company's OSRH Position: Q4 2024 in Review

Cowen and Company sold out of OSR Health (OSRH) in Q4 2024, closing a stake of 185,761 shares — an estimated $2.02M sold.

Cowen and Company first reported a position in OSRH in Q1 2023 and held it in 5 quarters. The position peaked at $3.94M in Q1 2024. 3 funds tracked by Wall St. Rank hold OSRH as of Q4 2024.

Cowen and Company reported no remaining OSR Health position as of Q4 2024 after selling out during the quarter.
Cowen and Company sold 185,761 OSR Health shares in Q4 2024, an estimated $2.02M.
Cowen and Company first reported a position in OSR Health in Q1 2023 and held it in 5 quarters.
Cowen and Company's OSR Health position peaked at $3.94M in Q1 2024.
3 funds tracked by Wall St. Rank held OSR Health as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.